Research Output per year
Personal profile
Research Interests
Anti-cancer therapeutics
Neuro oncology
Gynaecological cancers
Genitourinary cancers
Rare cancers - cancer of unknown primary, endocrine cancers and others
Supportive care
Neuro oncology
Gynaecological cancers
Genitourinary cancers
Rare cancers - cancer of unknown primary, endocrine cancers and others
Supportive care
Research Expertise
Cancer
Cancer Pharmacology
External positions
SALHN, Southern Adelaide Local Health Network
Fingerprint Dive into the research topics where Ganessan Kichenadasse is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 24 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
A literature review of treatment-specific clinical prediction models in patients with breast cancer
Modi, N. D., Sorich, M. J., Rowland, A., Logan, J. M., McKinnon, R. A., Kichenadasse, G., Wiese, M. D. & Hopkins, A. M., Apr 2020, In : Critical Reviews in Oncology/Hematology. 148, 8 p., 102908.Research output: Contribution to journal › Review article
Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer
Kichenadasse, G., Miners, J. O., Mangoni, A. A., Rowland, A., Hopkins, A. M. & Sorich, M. J., Apr 2020, In : JAMA Oncology. 6, 4, p. 512-518 7 p.Research output: Contribution to journal › Article
Bladder, penile, renal pelvis and testis cancers: A population based analysis of incidence and survival 1977-2013
Tempo, J., Logan, C., O'Callaghan, M., Kahokehr, A., Kichenadasse, G., D'Onise, K. & Foreman, D., Apr 2020, In : Cancer Epidemiology. 65, 8 p., 101692.Research output: Contribution to journal › Article
Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab
Hopkins, A. M., Kichenadasse, G., Karapetis, C. S., Rowland, A. & Sorich, M. J., 11 Jul 2020, In : European Urology. 78, 4, p. 540-543 4 p., 8972.Research output: Contribution to journal › Article
Development and validation of a prognostic model for patients with advanced lung cancer treated with the immune checkpoint inhibitor atezolizumab
Hopkins, A., Kichenadasse, G., Garrett-Meyer, E., Karapetis, C., Rowland, A. & Sorich, M. J., Jul 2020, In : Clinical Cancer Research. 26, 13, p. 3280-3286 7 p.Research output: Contribution to journal › Article